Influenza Vaccine Development
$1,489,572Z01FY2008AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications & trials
Abstract
Improved vaccines against influenza would enhance our ability to decrease the deleterious effects of epidemics. This study aims to develop genetic vaccination strategies against influenza. DNA and adenoviral vaccines have been developed against different strains of influenza, including the H5N1 avian flu and seasonal flu, and testing has been conducted to determine the optimal strategies for immunization. Several DNA vaccine candidates showed promising results and one avian influenza vaccine is being tested through the VRC Clinical Trials Core.
View original record on NIH RePORTER →